Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Biomarkers as Predictors of Recurrence following Curative Resection for Pancreatic Ductal Adenocarcinoma: A Review
Authors
Keywords
-
Journal
Biomed Research International
Volume 2014, Issue -, Pages 1-10
Publisher
Hindawi Limited
Online
2014-06-25
DOI
10.1155/2014/468959
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Immunohistochemically Detected Expression of 3 Major Genes (CDKN2A/p16, TP53, and SMAD4/DPC4) Strongly Predicts Survival in Patients With Resectable Pancreatic Cancer
- (2013) Minoru Oshima et al. ANNALS OF SURGERY
- Failure Patterns in Resected Pancreas Adenocarcinoma
- (2013) Jordan M. Winter et al. ANNALS OF SURGERY
- The Expression of PTEN Is Associated With Improved Prognosis in Patients With Ampullary Adenocarcinoma After Pancreaticoduodenectomy
- (2013) Stuti Shroff et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications
- (2013) Kjersti Tjensvoll et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival
- (2013) Ziman Zhu et al. JOURNAL OF SURGICAL ONCOLOGY
- Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors
- (2013) Tina Sharma et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
- (2013) Brian E. Kadera et al. PLoS One
- Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
- (2012) J. B. Bachet et al. ANNALS OF ONCOLOGY
- A preclinical and clinical review of aflibercept for the management of cancer
- (2012) Andrew Gaya et al. CANCER TREATMENT REVIEWS
- Advances in Biomarker Research for Pancreatic Cancer
- (2012) Kruttika Bhat et al. CURRENT PHARMACEUTICAL DESIGN
- Loss of phosphatase and tensin homolog expression is associated with recurrence and poor prognosis in patients with pancreatic ductal adenocarcinoma
- (2012) Wai Chin Foo et al. HUMAN PATHOLOGY
- A preclinical and clinical study of mycophenolate mofetil in pancreatic cancer
- (2012) J. Rodríguez-Pascual et al. INVESTIGATIONAL NEW DRUGS
- Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma
- (2012) Teiichi Sugiura et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer
- (2012) Jordan M. Winter et al. JOURNAL OF SURGICAL ONCOLOGY
- Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer
- (2011) Shojiro Hata et al. ANNALS OF SURGICAL ONCOLOGY
- MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- Phase II Trial of Cetuximab, Gemcitabine, and Oxaliplatin Followed by Chemoradiation With Cetuximab for Locally Advanced (T4) Pancreatic Adenocarcinoma: Correlation ofSmad4(Dpc4)Immunostaining With Pattern of Disease Progression
- (2011) Christopher H. Crane et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Potential of MicroRNAs in Pancreatic Ductal Adenocarcinoma
- (2011) Colin W. Steele et al. PANCREAS
- Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma
- (2011) G. Garcea et al. WORLD JOURNAL OF SURGERY
- PTEN Is a Major Tumor Suppressor in Pancreatic Ductal Adenocarcinoma and Regulates an NF-κB–Cytokine Network
- (2011) Haoqiang Ying et al. Cancer Discovery
- Preoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratio
- (2010) Imran Bhatti et al. AMERICAN JOURNAL OF SURGERY
- Failure of Normalization of CA19-9 Following Resection for Pancreatic Cancer is Tantamount to Metastatic Disease
- (2010) Sherif R. Z. Abdel-Misih et al. ANNALS OF SURGICAL ONCOLOGY
- Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer
- (2010) Xin An et al. BIOMARKERS
- PTEN Loss Accelerates KrasG12D-Induced Pancreatic Cancer Development
- (2010) R. Hill et al. CANCER RESEARCH
- Prognostic Impact of RT-PCR-Based Detection of Peritoneal Micrometastases in Patients with Pancreatic Cancer Undergoing Curative Resection
- (2009) Kaitlyn J. Kelly et al. ANNALS OF SURGICAL ONCOLOGY
- High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinoma
- (2009) R Maréchal et al. BRITISH JOURNAL OF CANCER
- A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer
- (2009) H Ueno et al. BRITISH JOURNAL OF CANCER
- Systemic inflammation, nutritional status and survival in patients with cancer
- (2009) Donald C McMillan CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Role of systemic inflammatory response in predicting survival in patients with primary operable cancer
- (2009) Campbell SD Roxburgh et al. Future Oncology
- Detection of micrometastases in peritoneal washings of gastric cancer patients by the reverse transcriptase polymerase chain reaction
- (2009) Kimberly Moore Dalal et al. Gastric Cancer
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
- (2009) Christine A. Iacobuzio-Donahue et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic value of metastin expression in human pancreatic cancer
- (2009) Kazuyuki Nagai et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- A Compendium of Potential Biomarkers of Pancreatic Cancer
- (2009) H. C. Harsha et al. PLOS MEDICINE
- CA 19-9 Velocity Predicts Disease-Free Survival and Overall Survival After Pancreatectomy of Curative Intent
- (2008) Jonathan M. Hernandez et al. JOURNAL OF GASTROINTESTINAL SURGERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search